Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
Filed with ASX · · 3 pages · English
Cynata Therapeutics Limited on 6ix
Earlier from Cynata Therapeutics
- CYP MSC Data in Asthma Model Published in Sceintific Journal
- Cynata Files New Patent Application for Cymerus in Oncology
- United States Patent for Core Cynata Technology
- Treatment Commences in Cynatas World First Clinical Trial
- March 2017 Quarterly Report
Later from Cynata Therapeutics
- FDA Meeting Provides Clear Path for US Development Plans
- June 2017 Quarterly Report
- Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
- Health Canada Meeting Advances CYP Global Development Plans
- US Patent Granted for Cynata Cymerus Technology
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics